Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,095 public trials 2,042 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma

NCT00865969

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Wilshire Oncology Medical Group, Inc La Verne, California, United States
  • Comprehensive Cancer Center Palm Springs, California, United States
  • Yale Cancer Center-Section of Medical Oncology New Haven, Connecticut, United States
View all 117 locations
View Trial Details
Completed

Brentuximab Vedotin and Gemcitabine Hydrochloride in Treating Younger Patients With Relapsed or Refractory Hodgkin Lymphoma

NCT01780662

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +9 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Kaiser Permanente Downey Medical Center Downey, California, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
View all 116 locations
View Trial Details
Completed

Single vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501)

NCT00412360

Conditions
Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +24 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Childrens Hospital at Oakland Oakland, California, United States
View all 38 locations
View Trial Details
Completed

Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease

NCT00000626

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +23 more
Locations
  • Alabama Therapeutics CRS Birmingham, Alabama, United States
  • USC CRS Los Angeles, California, United States
  • Northwestern University CRS Chicago, Illinois, United States
  • Indiana Univ. School of Medicine, Infectious Disease Research Clinic Indianapolis, Indiana, United States
View Trial Details

Related conditions